Using Nomogram with Imaging to Assess Axillary Disease Burden after Neoadjuvant Chemotherapy for Clinical Node-Positive Breast Cancer

被引：0
|
作者：
Roldan, Estefania
Bharani, Tina
James, Ted A.
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Philadelphia, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2023年 / 237卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [41] Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Toan T. Nguyen
    Tanya L. Hoskin
    Courtney N. Day
    Amy C. Degnim
    James W. Jakub
    Tina J. Hieken
    Judy C. Boughey
    Annals of Surgical Oncology, 2018, 25 : 2596 - 2602
  • [42] Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy
    Iwamoto, Naoko
    Aruga, Tomoyuki
    Horiguchi, Shinichiro
    Saita, Chiaki
    Onishi, Mai
    Goto, Risa
    Ishiba, Toshiyuki
    Honda, Yayoi
    Miyamoto, Hiromi
    Kuroi, Katsumasa
    SURGERY TODAY, 2020, 50 (02) : 178 - 184
  • [43] Is reliable Sentinel lymph node biopsy in axillary node-positive breast cancer patients after neoadjuvant chemotherapy?. Preliminary results
    Fuertes, S.
    Hernandez, G.
    Velasco, M.
    Linares, S.
    Sainz de la Cuesta, R.
    Martinez de Vega, V.
    Gonzalez, L.
    Maldonado, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S353 - S353
  • [44] Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Kandice Ludwig
    Amanda L. Kong
    Current Breast Cancer Reports, 2020, 12 : 391 - 397
  • [45] Comparing shear wave elastography of breast tumors and axillary nodes in the axillary assessment after neoadjuvant chemotherapy in patients with node-positive breast cancer
    Huang, Jia-Xin
    Liu, Feng-Tao
    Sun, Lu
    Ma, Chao
    Fu, Jia
    Wang, Xue-Yan
    Huang, Gui-Ling
    Zhang, Yu-Ting
    Pei, Xiao-Qing
    RADIOLOGIA MEDICA, 2024, 129 (08): : 1143 - 1155
  • [46] Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy
    Naoko Iwamoto
    Tomoyuki Aruga
    Shinichiro Horiguchi
    Chiaki Saita
    Mai Onishi
    Risa Goto
    Toshiyuki Ishiba
    Yayoi Honda
    Hiromi Miyamoto
    Katsumasa Kuroi
    Surgery Today, 2020, 50 : 178 - 184
  • [47] Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer
    Jose Vila
    Elizabeth A. Mittendorf
    Gabriel Farante
    Roland L. Bassett
    Paolo Veronesi
    Viviana Galimberti
    Nicolas Peradze
    Michael C. Stauder
    Mariana Chavez-MacGregor
    Jennifer F. Litton
    Lei Huo
    Henry M. Kuerer
    Kelly K. Hunt
    Abigail S. Caudle
    Annals of Surgical Oncology, 2016, 23 : 3501 - 3509
  • [48] Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
    Chen, Shin-Cheh
    Yu, Chi-Chang
    Chang, Hsien-Kun
    Lin, Yung-Chang
    Lo, Yung-Feng
    Shen, Shih-Che
    Kuo, Wen-Lin
    Tsai, Hsiu-Pei
    Chou, Hsu-Huan
    Chu, Chia-Hui
    Shen, Wen-Chi
    Wu, Ren-Chin
    Ueng, Shir-Hwa
    Huang, Yi-Ting
    JOURNAL OF CANCER, 2021, 12 (17): : 5365 - 5374
  • [49] Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer
    Ouldamer, Lobna
    Chas, Marie
    Arbion, Flavie
    Body, Gilles
    Cirier, Julien
    Ballester, Marcos
    Bendifallah, Sofiane
    Darai, Emile
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 158 - 165
  • [50] Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients
    Li, Zhuoxuan
    Tong, Yiwei
    Chen, Xiaosong
    Shen, Kunwei
    FRONTIERS IN ONCOLOGY, 2022, 12
12345